CROSS CTRY HEALTHCARE INC's ticker is CCRN and the CUSIP is 227483104. A total of 142 filers reported holding CROSS CTRY HEALTHCARE INC in Q2 2017. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,908,536 | -24.2% | 788,008 | +2.6% | 0.00% | 0.0% |
Q1 2024 | $14,385,275 | -15.7% | 768,352 | +1.9% | 0.00% | -50.0% |
Q4 2023 | $17,072,541 | -4.9% | 754,003 | +4.1% | 0.00% | 0.0% |
Q3 2023 | $17,956,349 | -8.8% | 724,251 | +3.3% | 0.00% | 0.0% |
Q2 2023 | $19,683,022 | +24.9% | 700,962 | -0.7% | 0.00% | 0.0% |
Q1 2023 | $15,754,602 | +86970.9% | 705,851 | +3.7% | 0.00% | -33.3% |
Q4 2022 | $18,094 | -99.9% | 680,994 | +1.6% | 0.00% | 0.0% |
Q3 2022 | $19,007,000 | +40.0% | 670,003 | +2.8% | 0.00% | +50.0% |
Q2 2022 | $13,580,000 | -2.1% | 651,962 | +1.8% | 0.00% | 0.0% |
Q1 2022 | $13,871,000 | -18.8% | 640,143 | +4.1% | 0.00% | 0.0% |
Q4 2021 | $17,076,000 | +31.8% | 615,146 | +0.8% | 0.00% | 0.0% |
Q3 2021 | $12,958,000 | +28.6% | 610,084 | -0.0% | 0.00% | +100.0% |
Q2 2021 | $10,073,000 | +36.7% | 610,168 | +3.4% | 0.00% | 0.0% |
Q1 2021 | $7,369,000 | +57.6% | 590,020 | +11.9% | 0.00% | 0.0% |
Q4 2020 | $4,675,000 | +33.2% | 527,142 | -2.5% | 0.00% | 0.0% |
Q3 2020 | $3,510,000 | +7.8% | 540,881 | +2.3% | 0.00% | 0.0% |
Q2 2020 | $3,255,000 | -6.9% | 528,611 | +1.9% | 0.00% | 0.0% |
Q1 2020 | $3,495,000 | -69.0% | 518,585 | -46.6% | 0.00% | 0.0% |
Q4 2019 | $11,292,000 | +129.2% | 971,818 | +103.1% | 0.00% | 0.0% |
Q3 2019 | $4,927,000 | +15.8% | 478,383 | +5.5% | 0.00% | 0.0% |
Q2 2019 | $4,254,000 | +42.8% | 453,546 | +7.1% | 0.00% | 0.0% |
Q1 2019 | $2,978,000 | -47.0% | 423,660 | -44.8% | 0.00% | 0.0% |
Q4 2018 | $5,624,000 | +78.8% | 767,590 | +113.0% | 0.00% | 0.0% |
Q3 2018 | $3,145,000 | -18.1% | 360,351 | +5.6% | 0.00% | 0.0% |
Q2 2018 | $3,839,000 | +9.8% | 341,288 | +8.4% | 0.00% | 0.0% |
Q1 2018 | $3,496,000 | -10.1% | 314,769 | +3.2% | 0.00% | 0.0% |
Q4 2017 | $3,890,000 | -7.9% | 304,924 | +2.7% | 0.00% | -50.0% |
Q3 2017 | $4,225,000 | +13.8% | 296,933 | +3.2% | 0.00% | +100.0% |
Q2 2017 | $3,713,000 | -3.9% | 287,651 | +6.9% | 0.00% | -50.0% |
Q1 2017 | $3,862,000 | -4.2% | 268,995 | +4.1% | 0.00% | 0.0% |
Q4 2016 | $4,033,000 | +53.1% | 258,413 | +15.5% | 0.00% | +100.0% |
Q3 2016 | $2,635,000 | -13.4% | 223,745 | +2.4% | 0.00% | -50.0% |
Q2 2016 | $3,042,000 | +20.0% | 218,551 | +0.3% | 0.00% | +100.0% |
Q1 2016 | $2,534,000 | -24.1% | 217,889 | +7.0% | 0.00% | -50.0% |
Q4 2015 | $3,338,000 | +21.8% | 203,670 | +1.1% | 0.00% | 0.0% |
Q3 2015 | $2,740,000 | +14.3% | 201,395 | +6.5% | 0.00% | +100.0% |
Q2 2015 | $2,397,000 | +5.0% | 189,143 | -1.7% | 0.00% | 0.0% |
Q1 2015 | $2,282,000 | +0.5% | 192,493 | +5.7% | 0.00% | 0.0% |
Q4 2014 | $2,271,000 | +40.3% | 182,068 | +4.4% | 0.00% | 0.0% |
Q3 2014 | $1,619,000 | +55.2% | 174,351 | +8.9% | 0.00% | 0.0% |
Q2 2014 | $1,043,000 | -31.3% | 160,103 | -14.9% | 0.00% | 0.0% |
Q1 2014 | $1,518,000 | -17.2% | 188,203 | +2.4% | 0.00% | 0.0% |
Q4 2013 | $1,833,000 | +123.5% | 183,733 | +35.8% | 0.00% | 0.0% |
Q3 2013 | $820,000 | +21.7% | 135,345 | +3.6% | 0.00% | 0.0% |
Q2 2013 | $674,000 | – | 130,634 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simcoe Capital Management, LLC | 1,143,625 | $23,822,000 | 3.28% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,194,340 | $45,708,000 | 1.59% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 704,526 | $14,676,000 | 1.51% |
Mesirow Financial Investment Management, Inc. | 12,643 | $263,000 | 1.27% |
Aristotle Capital Boston, LLC | 1,638,612 | $34,132,000 | 1.02% |
Zebra Capital Management LLC | 14,351 | $299,000 | 0.88% |
Alpha DNA Investment Management LLC | 49,398 | $1,028,000 | 0.88% |
SummerHaven Investment Management, LLC | 55,577 | $1,158,000 | 0.78% |
GLOBEFLEX CAPITAL L P | 145,700 | $3,035,000 | 0.74% |
OBERWEIS ASSET MANAGEMENT INC/ | 96,900 | $2,018,000 | 0.51% |